![Ervin Veszprémi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ervin Veszprémi
Plus aucun poste en cours
Profil
Ervin Veszprémi formerly worked at Medichem SA, as Chief Executive Officer from 2003 to 2014, Invent Invest Holding SL, as Chief Executive Officer from 2015 to 2016, Genmedica Therapeutics SL, as Chairman, Kindred Biosciences, Inc., as Independent Director from 2013 to 2021, Amersham Corp., as Head-Business Unit, Novartis Groupe France SA, as Vice President, Novartis Animal Health US, Inc., as Vice President & Global Head-Marketing in 2002, and Pharmacia Spain SA, as Head-Business Unit.
Mr. Veszprémi received his undergraduate degree from the University of British Columbia.
Anciens postes connus de Ervin Veszprémi
| Sociétés | Poste | Fin |
|---|---|---|
| KINDRED BIOSCIENCES, INC. | Directeur/Membre du Conseil | 27/08/2021 |
Invent Invest Holding SL
 Invent Invest Holding SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Directeur Général | 04/10/2016 |
Medichem SA
 Medichem SA Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical ingredients | Directeur Général | 01/01/2014 |
Novartis Groupe France SAS
 Novartis Groupe France SAS Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | - |
Novartis Animal Health US, Inc.
 Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for animals | Sales & Marketing | 01/01/2002 |
Formation de Ervin Veszprémi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Amersham Corp.
 Amersham Corp. Investment ManagersFinance Amersham Corp. focuses on the acquisition and ownership of mid-sized manufactures of precision engineered components and assemblies with particular interest in aerospace, automotive and medical device manufacturers and suppliers. The firm invests in small to medium sized companies with annual sales of $10 million to $200 million | Finance |
Kindred Biosciences, Inc.
 Kindred Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for animals | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Groupe France SAS
Novartis Groupe France SAS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Engages in the research and development of treatments for metabolic disorders | Health Technology |
Novartis Animal Health US, Inc.
Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for animals | Health Technology |
Medichem SA
Medichem SA Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical ingredients | Health Technology |
Pharmacia Spain SA | |
Invent Invest Holding SL
Invent Invest Holding SL Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Choisissez Zonebourse 
